A. James Mixson

3.4k total citations
69 papers, 2.7k citations indexed

About

A. James Mixson is a scholar working on Molecular Biology, Genetics and Biomaterials. According to data from OpenAlex, A. James Mixson has authored 69 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 10 papers in Genetics and 9 papers in Biomaterials. Recurrent topics in A. James Mixson's work include RNA Interference and Gene Delivery (37 papers), Advanced biosensing and bioanalysis techniques (25 papers) and Nanoparticle-Based Drug Delivery (9 papers). A. James Mixson is often cited by papers focused on RNA Interference and Gene Delivery (37 papers), Advanced biosensing and bioanalysis techniques (25 papers) and Nanoparticle-Based Drug Delivery (9 papers). A. James Mixson collaborates with scholars based in United States, Netherlands and Spain. A. James Mixson's co-authors include Qixin Leng, Martin C. Woodle, Sanford A. Stass, B D Weintraub, Puthupparampil V. Scaria, Na Zhao, Bruce D. Weintraub, Roberto Parrilla, Qingqing Leng and J H McClaskey and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

A. James Mixson

68 papers receiving 2.7k citations

Peers

Countries citing papers authored by A. James Mixson

Since Specialization

Citations

This map shows the geographic impact of A. James Mixson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. James Mixson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. James Mixson more than expected).

Fields of papers citing papers by A. James Mixson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. James Mixson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. James Mixson. The network helps show where A. James Mixson may publish in the future.

Co-authorship network of co-authors of A. James Mixson

This figure shows the co-authorship network connecting the top 25 collaborators of A. James Mixson. A scholar is included among the top collaborators of A. James Mixson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. James Mixson. A. James Mixson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	pH modification of gel mobility shift improves polyplex selection In Vivo 2024 ·Biochemical and Biophysical Research Communications ·Qingqing Leng, (unknown), A. James Mixson	2
2	A Facile and Promising Delivery Platform for siRNA to Solid Tumors 2024 ·Molecules ·Qixin Leng, (unknown), A. James Mixson	2
3	NRP1 transport of cancer therapeutics mediated by tumor-penetrating peptides 2017 ·Drugs of the Future ·Qixin Leng, Martin C. Woodle, A. James Mixson	14
4	Silver adducts of four-branched histidine rich peptides exhibit synergistic antifungal activity 2016 ·Biochemical and Biophysical Research Communications ·Qixin Leng, Martin C. Woodle, Yijia Liu, A. James Mixson	2
5	Direct Observation of Dynamic Mechanical Regulation of DNA Condensation by Environmental Stimuli 2014 ·Angewandte Chemie International Edition ·Amy S. Lee, (unknown), (unknown), (unknown), (unknown), Szu‐Ting Chou, (unknown), (unknown), (unknown), Qixin Leng, Jason D. Kahn, A. James Mixson, Joonil Seog	10
6	Enhanced silencing and stabilization of siRNA polyplexes by histidine-mediated hydrogen bonds 2013 ·Biomaterials ·Szu‐Ting Chou, Kellie Hom, Daoning Zhang, Qixin Leng, (unknown), (unknown), Amy S. Lee, Michael J. Shapiro, Joonil Seog, Jason D. Kahn, A. James Mixson	62
7	Zinc finger nucleases: Tailor-made for gene therapy 2012 ·Drugs of the Future ·Szu‐Ting Chou, Qingqing Leng, A. James Mixson	16
8	Advances in systemic siRNA delivery 2009 ·Drugs of the Future ·Qingqing Leng, Martin C. Woodle, Patrick Lu, A. James Mixson	53
9	Human rhomboid family-1 gene silencing causes apoptosis or autophagy to epithelial cancer cells and inhibits xenograft tumor growth 2008 ·Molecular Cancer Therapeutics ·Zhenwen Yan, Huafei Zou, Tian Fang, Jennifer R. Grandis, A. James Mixson, Patrick Lu, Luyuan Li	75
10	Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenografts 2008 ·Cancer Gene Therapy ·Qingqing Leng, Puthupparampil V. Scaria, Patrick Lu, Martin C. Woodle, A. James Mixson	44
11	A branched histidine/lysine peptide, H2K4b, in complex with plasmids encoding antitumor proteins inhibits tumor xenografts 2006 ·The Journal of Gene Medicine ·Qixin Leng, Puthupparampil V. Scaria, Olga B. Ioffe, Martin C. Woodle, A. James Mixson	22
12	Small interfering RNA targeting Raf-1 inhibits tumor growth in vitro and in vivo 2005 ·Cancer Gene Therapy ·Qixin Leng, A. James Mixson	70
13	Transporting silence: Design of carriers for siRNA to angiogenic endothelium 2005 ·Journal of Controlled Release ·Raymond M. Schiffelers, A. James Mixson, (unknown), Marcel H.A.M. Fens, (unknown), Qin Zhou, Jun Xu, Grietje Molema, Patrick Lu, Puthupparampil V. Scaria, Gert Storm, Martin C. Woodle	34
14	DNA Delivery to Cells in Culture Using Peptides 2004 ·Humana Press eBooks ·Lei Zhang, Nicholas P. Ambulos, A. James Mixson	12
15	Targeting Tumor Angiogenesis with Gene Therapy 2001 ·Molecular Genetics and Metabolism ·Qingrong Chen, Lei Zhang, Warren J. Gasper, A. James Mixson	38
16	Co-polymer of histidine and lysine markedly enhances transfection efficiency of liposomes 2000 ·Gene Therapy ·(unknown), (unknown), Sanford A. Stass, A. James Mixson	62
17	Parenteral Gene Therapy with p53 Inhibits Human Breast Tumors In Vivo Through a Bystander Mechanism Without Evidence of Toxicity 1997 ·Human Gene Therapy ·Min Xu, Dhiren Kumar, S. Srinivas, Louis J. DeTolla, Seon‐Mi Yu, Sanford A. Stass, A. James Mixson	106
18	Analysis of the binding of 3,3',5-triiodo-L-thyronine and its analogs to mutant human .beta.1 thyroid hormone receptors: A model of the hormone binding site 1994 ·Biochemistry ·Sheue-yann Cheng, Stephen C. Ransom, Peter McPhie, (unknown), A. James Mixson, Bruce D. Weintraub	22
19	Identification of a novel mutation in the gene encoding the β‐triiodothyronine receptor in a patient with apparent selective pituitary resistance to thyroid hormone 1993 ·Clinical Endocrinology ·A. James Mixson, Justine Renault, Stephen C. Ransom, Donald Bodenner, B D Weintraub	37
20	Differential expression of mutant and normal beta T3 receptor alleles in kindreds with generalized resistance to thyroid hormone. 1993 ·Journal of Clinical Investigation ·A. James Mixson, Péter Hauser, G E Tennyson, Justine Renault, Donald Bodenner, B D Weintraub	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact